• 1
    Curry W, Kulling D. Newer antiepileptic drugs: gabapentin, lamotrigine, felbamate, topiramate and fosphenytoin. Am Fam Physician 1998;57:51320.
  • 2
    Goa K, Ross S, Chrisp P. Lamotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1993;46:15276.
  • 3
    Burstein A. Lamotrigine. Pharmacotherapy 1995;15:12943.
  • 4
    Elwes R, Binnie C. Clinical pharmacokinetics of newer antiepileptic drugs: lamotrigine, vigabatrin, gabapentin and oxcarbazepine. Clin Pharmacokinet 1996;30:40315.
  • 5
    Cleland P. Risk benefit assessment of anticonvulsants in women of childbearing potential. Drug Safety 1991;6:7081.
  • 6
    Lander C, Eadie M. Plasma antiepileptic drug concentrations during pregnancy. Epilepsia 1991;32:25766.
  • 7
    Tomson T, Lindbom U, Ekqvist B, Sundqvist A. Disposition of carbamazepine and phenytoin in pregnancy. Epilepsia 1994;35:1315.
  • 8
    Tomson T, Ohman I, Vitols S. Lamotrigine in pregnancy and lactation: a case report. Epilepsia 1997;38:103941.
  • 9
    Vine L. Breeding. In: VineL, ed. Breeding, whelping, and natal care of dogs. New York : Arco Publishing Company, 1977:2748.
  • 10
    Concannon P. Physiology and endocrinology of canine pregnancy. In: MorrowD, ed. Current therapy in theriogenology. Philadelphia : WB Saunders, 1986:4917.
  • 11
    Matar K, Nicholls P, Bawazir S, Al-Hassan M, Tekle A. A rapid liquid chromatographic method for the determination of lamotrigine in plasma. J Pharm Biomed Anal 1998;17:52531.
  • 12
    Concannon P. Canine pregnancy and parturition. Vet Clin North Am Small Anim Pract 1986;16:45375.
  • 13
    Olson P, Husted P. Breeding management for optimal reproductive efficiency in the bitch and stud dog. In: MorrowD, ed. Current therapy in theriogenology. Philadelphia : WB Saunders, 1986:4636.
  • 14
    Concannon P, McCann J, Temple M. Biology and endocrinology of ovulation, pregnancy and parturition in the dog. J Reprod Fertil Suppl 1989;39:325.
  • 15
    Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 1997;33:32843.
  • 16
    Boyce E, Nappi J. Is there significance beyond t-test Drug Intell Clin Pharm 1988;22:3345.
  • 17
    Furlanut M, Benetello P, Avogaro A, Dainese R. Effects of folic acid on phenytoin kinetics in healthy subjects. Clin Pharmacol Ther 1978;24:2947.
  • 18
    Neale M, Parke D. Effects of pregnancy on the metabolism of drugs in the rat and rabbit. Biochem Pharmacol 1973;22:145161.
  • 19
    Crawford J, Rudofsky S. Some alterations in the pattern of drug metabolism associated with pregnancy, oral contraceptives and the newly-born. Br J Anaesth 1966;38:44654.
  • 20
    Hunter J. Enzyme induction and inhibition in human pregnancy. In: RichensA and WoodfordF, eds. Anticonvulsant drugs and enzyme induction. Amsterdam : Elsevier, 1976:1313.
  • 21
    Dunihoo D. Maternal physiology. In: DunihooD, ed. Fundamentals of gynecology and obstetrics. Philadelphia : JB Lippincott, 1992:2804.
  • 22
    Davidson J, Hytten F. Glomerular filtration during and after pregnancy. J Obstet Gynaecol 1974;81:58895.